Shane Lewin
CEO, Clockwork Bio
Shane has been building AI products, applications, and organizations for over 20 years, spanning multiple industries, startups and large organizations. Over the past decade, as the Vice president of AI and ML and GSK, he was part of the team that built the AIML organization from the ground up, delivering >20 successful programs at all stages of the drug discovery pipeline. It was there that he saw an opportunity that needed to be fixed in the pipeline and left to found Clockwork Bio, where he’s building a fully AI native drug pipeline for complex diseases with the goal to end cancer once and for all.
A former mathematician, he dropped out of his PhD program @Stanford with a masters degree to join a startup and never looked back.